| Literature DB >> 34815498 |
Qi Liao1, Ziyu Chen1, Yanlin Tao1, Beibei Zhang1, Xiaojun Wu1, Li Yang2, Qingzhong Wang3, Zhengtao Wang1.
Abstract
The current severe situation of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been reversed and posed great threats to global health. Therefore, there is an urgent need to find out effective antiviral drugs. The 3-chymotrypsin-like protease (3CLpro) in SARS-CoV-2 serve as a promising anti-virus target due to its essential role in the regulation of virus reproduction. Here, we report an improved integrated approach to identify effective 3CLpro inhibitors from effective Chinese herbal formulas. With this approach, we identified the 5 natural products (NPs) including narcissoside, kaempferol-3-O-gentiobioside, rutin, vicenin-2 and isoschaftoside as potential anti-SARS-CoV-2 candidates. Subsequent molecular dynamics simulation additionally revealed that these molecules can be tightly bound to 3CLpro and confirmed effectiveness against COVID-19. Moreover, kaempferol-3-o-gentiobioside, vicenin-2 and isoschaftoside were first reported to have SARS-CoV-2 3CLpro inhibitory activity. In summary, this optimized integrated strategy for drug screening can be utilized in the discovery of antiviral drugs to achieve rapid acquisition of drugs with specific effects on antiviral targets.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34815498 PMCID: PMC8611036 DOI: 10.1038/s41598-021-02266-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart represents the workflow of integrated structure-based anti-coronavirus NPs screening.
Figure 2SARS-CoV-2 3CLpro in vitro dose–response inhibition assay and IC50 value detection. (a) Narcissoside. (b) Kaempferol-3-O-gentiobioside. (c) Rutin. (d) Vicenin-2. (e) Isoschaftoside.
Figure 3Kinetic binding curve of 5 3CLpro inhibitors measured by SPR experiment. (a) Narcissoside. (b) Kaempferol-3-O-gentiobioside. (c) Rutin. (d) Vicenin-2. (e) Isoschaftoside. (f) The dissociation equilibrium constant (KD) value of the five natural inhibitors.
Summary of ranking, equilibrium dissociation constants (KD) and IC50 values for SARS-CoV-2 3CLpro inhibitors.
| Compound | Molecular weight (Da) | Rank | IC50 (µM) | |
|---|---|---|---|---|
| Narcissoside | 624.544 | 0.744 | 9.995 | 38.142 |
| Kaempferol-3-O-gentiobioside | 610.518 | 0.861 | 2.694 | 35.892 |
| Rutin | 610.518 | 0.801 | 1.525 | 31.259 |
| Vicenin-2 | 594.518 | 0.771 | 8.583 | 38.856 |
| Isoschaftoside | 564.492 | 0.765 | 11.370 | 30.220 |
Figure 4The RMSD values and contribution of various energy items to binding free energy in drug-3CLpro simulation. (a) Root mean square deviation (RMSD) of the 5 3CLpro-ligand complexes from the 100 ns MD simulations. Narcissoside (blue), kaempferol-3-O-gentiobioside (red), rutin (black), vicenin-2 (green) and isoschaftoside (Violet). (b) Residues with a high contribution to the total binding energy during the MD simulation of the 5 protein-inhibitor complexes. Narcissoside (blue), kaempferol-3-O-gentiobioside (red), rutin (black), vicenin-2 (green) and isoschaftoside (violet). (c) The general structure of narcissoside, kaempferol-3-O-gentiobioside and rutin. (d) Root mean square deviation (RMSD) of the 5 ligand from the 100 ns MD simulations. Narcissoside (blue), kaempferol-3-O-gentiobioside (red), rutin (black), vicenin-2 (green) and isoschaftoside (Violet). (e) The contribution of various energy items to the total binding energy of 3CLpro inhibitors. Narcissoside (blue), kaempferol-3-O-gentiobioside (red), rutin (black), vicenin-2 (green) and isoschaftoside (violet). f The general structure of vicenin-2 and isoschaftoside.
The results of molecular MM/PBSA free energy calculation (kcal/mol) and relevant ranking.
| Compound | ΔEvdw | ΔEele | ΔEPB | ΔESA | ΔGTot | Rank |
|---|---|---|---|---|---|---|
| Narcissoside | − 58.32 | − 21.59 | 69.90 | − 6.30 | − 16.31 | 0.744 |
| Kaempferol-3-O-gentiobioside | − 47.22 | − 58.54 | 90.81 | − 5.89 | − 20.84 | 0.861 |
| Rutin | − 45.20 | − 43.78 | 72.26 | − 5.59 | − 22.31 | 0.801 |
| Vicenin-2 | − 42.68 | − 53.40 | 83.16 | − 5.80 | − 18.72 | 0.771 |
| Isoschaftoside | − 50.61 | − 66.58 | 103.47 | − 5.95 | − 19.67 | 0.765 |
Figure 5Binding mode of 5 NPs inhibitors to SARS-CoV-2 3CLpro. The protein and ligand are shown in gray and green, respectively. H-bond interactions are demonstrated by yellow dotted lines and residues forming H-bonds are shown in cyan. The surface of the protein is represented in cyan. The residues His41 and Met49 are highlighted in red to show the binding posture of the inhibitor. (a) Binding interaction of narcissoside. (b) Binding interaction of kaempferol-3-O-gentiobioside. (c) Binding interaction of rutin. (d) Binding interaction of vicenin-2. (e) Binding interaction of isoschaftoside. (f) Binding posture of narcissoside. (g) Binding posture of kaempferol-3-O-gentiobioside. (h) Binding posture of rutin. (i) Binding posture of vicenin-2. (j) Binding posture of isoschaftoside.